Cargando…
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
It is well known that certain active ingredients of the plants of Cannabis genus, i.e., the “phytocannabinoids” [pCBs; e.g., (−)-trans-Δ(9)-tetrahydrocannabinol (THC), (−)-cannabidiol, etc.] can influence a wide array of biological processes, and the human body is able to produce endogenous analogs...
Autores principales: | Oláh, Attila, Szekanecz, Zoltán, Bíró, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686045/ https://www.ncbi.nlm.nih.gov/pubmed/29176975 http://dx.doi.org/10.3389/fimmu.2017.01487 |
Ejemplares similares
-
Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal?
por: Oláh, Attila, et al.
Publicado: (2017) -
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
por: Tóth, Kinga Fanni, et al.
Publicado: (2019) -
Ly49 Receptors: Innate and Adaptive Immune Paradigms
por: Rahim, Mir Munir A., et al.
Publicado: (2014) -
Biosimilars: To switch or not to switch – that is the question
por: Szekanecz, Zoltán
Publicado: (2020) -
Occurrences and Functions of Ly6C(hi) and Ly6C(lo) Macrophages in Health and Disease
por: Li, Yuan-hui, et al.
Publicado: (2022)